Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
Abstract Background Hepatitis C is curable with direct-acting antivirals (DAAs). However, treatment uptake remains low among marginalized populations such as people who inject drugs. We sought to understand challenges to treatment uptake with DAAs among people living with hepatitis C and compare tre...
Saved in:
Main Authors: | Tony Antoniou (Author), Cheryl Pritlove (Author), Dana Shearer (Author), Mina Tadrous (Author), Hemant Shah (Author), Tara Gomes (Author) |
---|---|
Format: | Book |
Published: |
BMC,
2023-06-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Correction: Accessing hepatitis C direct acting antivirals among people living with hepatitis C: a qualitative study
by: Tony Antoniou, et al.
Published: (2023) -
Bioequivalent pharmacokinetics for generic and originator hepatitis C direct-acting antivirals
by: Andrew Hill, et al.
Published: (2018) -
Barriers to access to hepatitis C treatment with direct-acting antivirals in people who inject drugs in the community setting
by: Elena Yela, et al.
Published: (2024) -
IP-10 Interferes With the Antiviral Response of Direct-Acting Antiviral Agents for Hepatitis C Virus Infection
by: Yadong Wang, et al.
Published: (2022) -
P20 Monitoring the uptake of hepatitis C: direct acting antiviral treatment in Australia
by: B. Hajarizadeh, et al.
Published: (2017)